Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

🩺 Protocol Summary

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

Primary Research Facility: The University of Michigan (Ann Arbor, Michigan)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Obstructive Sleep Apnea?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 3 Years and 21 Years?

🔍 Protocol Specified Age Range: 3 Years to 21 Years

Able to attend required clinic visits at The University of Michigan (Ann Arbor, Michigan)?

🔍 Logistical Requirement: Site at The University of Michigan

📍 Primary Site Map

Site: The University of Michigan — Ann Arbor, Michigan

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.